Back to the top

Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for the deadliest cancers by stimulating radical collaboration.

Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for the deadliest cancers by stimulating radical collaboration.

Empowers

Break Through Cancer is committed to reducing the day-to-day barriers to cross-institutional collaboration such as contract negotiations, data sharing, intellectual property, and authorship policies.

Outstanding Researchers and Physicians

Break Through Cancer is a first-of-its-kind collaboration of five of the top cancer research centers in the world: Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MIT’s Koch Institute for Integrative Cancer Research, The University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center.

deadliestcancers

Break Through Cancer is focused on several of the world’s deadliest cancers. These are diseases with poor prognoses for which progress has been very slow.

Radicalcollaboration

Radical collaboration is the expectation of all Break Through Cancer researchers, physicians, and other partners. Radical collaboration requires sharing discoveries and data in real time, a trust and willingness to critique each other’s ideas, and a sense of urgency knowing that lives are at stake.

“When we act together we have the potential to be an unstoppable force. There is nothing that will build momentum and progress faster.”

Tyler Jacks, PhD
President, Break Through Cancer

“When we act together we have the potential to be an unstoppable force. There is nothing that will build momentum and progress faster.”

Tyler Jacks, PhD
President, Break Through Cancer

IT’S ALL ABOUT THE PEOPLE

UPDATES AND NEWS

Press Release

Break Through Cancer Launches Team to Prevent Lung Cancer Recurrence with the Hope of Long-term Cures.

Press Release

Break Through Cancer Announces First Patient Enrolled in Phase 2 Trial Targeting Residual Disease in AML

Press Release

No More “Wait and See”: Two Clinical Trials Target the Origins of Recurrent Ovarian Cancer

Press Release

Break Through Cancer and ALK Positive, Inc. Team Up to Conquer ALK-Positive Lung Cancer with a $2 Million, Multi-year, Research Partnership

MAKE A DIFFERENCE

Break Through Cancer was created in February 2021 with an extraordinary matching gift of $250,000,000. Every gift to the Foundation supports groundbreaking cancer research and helps us to meet our matching commitment.

For questions about giving please email Lisa Schwarz, Chief Philanthropy Officer at LMS@BreakThroughCancer.org

Break Through Cancer
101 Rogers Street
Suite 3A
Cambridge, MA 02142
Info@breakthroughcancer.org
1-800-757-9881